Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma

Radiology

Volumn 250, Issue 2, 2009, Pages 425-434

  Kim, Kyung Won ^a   Lee, Jeong Min ^a   Klotz, Ernst ^b   Park, Hee Sun ^a   Lee, Dong Ho ^a   Kim, Ji Young ^a   Kim, Soo Jin ^a   Kim, Se Hyung ^a   Lee, Jae Young ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University College of Medicine   (South Korea)

^b SIEMENS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; JACKKNIFE TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTAL VEIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; COLOR; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; ROC CURVE; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COLOR; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61749089775     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2501072196     Document Type: Article

References (20)

1. Baron RL, Peterson MS. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging- opportunities and pitfalls. RadioGraph- ics 2001;21(Spec Issue):S117-S132.
2. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42: 27-434.
3. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the arcelona-2000EuropeanAssociation for the Study of the Liver conference. J Hepatol 2001;35:421-430.
4. Fournier LS, Cuenod CA, de Bazelaire C, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepato- cellular carcinoma using a blood pool contrast agent. Eur Radiol 2004;14:2125-2133.
5. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE. Pretransplanta- tion surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000;217:743-749.
6. Furuse J, Maru Y, Yoshino M, et al. Assessment of arterial tumor vascularity in small hepatocel- lular carcinoma: comparison between color doppler ultrasonography and radiographic im- agings with contrast medium- dynamic CT, an- giography, and CT hepatic arteriography. Eur J Radiol 2000;36:20 -27.
7. Platt JF, Francis IR, Ellis JH, Reige KA. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases. J Comput Assist Tomogr 1997;21:348-354.
8. Platt JF, Francis IR, Ellis JH, Reige KA. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology 1997;205:49 -53.
9. Quiroga S, Sebastia C, Pallisa E, Castella E, Perez-Lafuente M, Alvarez-Castells A. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. RadioGraphics 2001;21:65- 81.
10. White MJ, O'Gorman RL, Charles-Edwards EM, et al. Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI. Br J Radiol 2007;80:113-120.
11. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 2003;226:24-28.
12. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
13. Lee KH, Choi BI, Han JK, Jang HJ, Kim TK, Han MC. Nodular hepatocellular carcinoma: variation of tumor conspicuity on single-level dynamic scan and optimization of fixed delay times for two-phase helical CT. J Comput Assist Tomogr 2000;24:212-218.
14. Chefd'hotel C, Hermosillo G, Faugeras O. Flows of diffeomorphisms for multimodal image registration. In: Proceedings of the IEEE International Symposium on Biomedical Imaging. INRIA, Sophia-Antipolis, France: 2002; 753-756.
15. Saddi KA, Chefd'hotel C, Cheriet F. Large deformation registration ofcontrast-enhanced images with volume-preserving constraint. In: Pluim JPW, Reinhardt JM, eds. Proceedings of The International Society for Optical Engineering (SPIE): medical imaging 2007-image processing. Vol 6512. Bellingham, Wash: SPIE, 2007; 651203.
16. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006;238:531-541.
17. Iannaccone R, Laghi A, Catalano C, et al. Hep- atocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005;234: 460 - 467.
18. Chakraborty DP. Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method. Acad Radiol 2006;13: 1187-1193.
19. Kim TK, Choi BI, Han JK, Chung JW, Park JH, Han MC. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 1998;208:597- 603.
20. Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol 2002;3:1-15.